Metlife, Inc. (NYSE: MET) has announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited to purchase up to 10,000 shares of Metlife, Inc. common stock from Metlife shareholders. Potemkin's offer price of $53.00 per share is approximately 34.42 percent lower than the $80.82 closing price of Metlife common stock on September 12, 2025.
Metlife has recommended that shareholders reject this offer, stating that it is significantly below the current market value of Metlife's common stock. The company has emphasized that it is not associated in any way with Potemkin, its mini-tender offer, or its mini-tender offer documents.
The offer from Potemkin is for approximately 0.00002 percent of Metlife's shares of common stock outstanding as of August 31, 2025. Shareholders who have not responded to Potemkin's offer have been urged to take no action, and those who have already tendered their shares may withdraw them prior to the expiration of the offer, which is currently scheduled for Tuesday, October 7, 2025, 5 p.m. Eastern Time.
Metlife has also encouraged shareholders to review carefully the "withdrawal rights" section of the offer documents and to obtain current market quotations for their shares, consult with their broker or financial advisor, and exercise caution with respect to Potemkin's offer. The company has requested that a copy of its news release be included with all distributions of materials relating to Potemkin's mini-tender offer related to shares of Metlife, Inc. common stock.
Metlife, Inc. (NYSE: MET) is a leading financial services company, providing insurance, annuities, employee benefits, and asset management to individual and institutional customers globally. Today the company's shares have moved -1.85% to a price of $78.975. If you want to know more, read the company's complete 8-K report here.
